196 related articles for article (PubMed ID: 24008003)
1. Rosuvastatin improves impaired endothelial function, lowers high sensitivity CRP, complement and immuncomplex production in patients with systemic sclerosis--a prospective case-series study.
Timár O; Szekanecz Z; Kerekes G; Végh J; Oláh AV; Nagy G; Csiki Z; Dankó K; Szamosi S; Németh Á; Soltész P; Szücs G
Arthritis Res Ther; 2013; 15(5):R105. PubMed ID: 24008003
[TBL] [Abstract][Full Text] [Related]
2. [Effect of therapy with rosuvastatin on lipid spectrum, factors of inflammation and endothelial function in patients with ischemic heart disease].
Sergienko IV; Samoĭlenko EIu; Masenko VP; Ezhov MV; Sumarokov AB; Tkachev GA; Pogorelova OA; Balakhonova TV; Naumov VG
Kardiologiia; 2006; 46(5):4-8. PubMed ID: 16858347
[TBL] [Abstract][Full Text] [Related]
3. Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH).
ter Avest E; Abbink EJ; Holewijn S; de Graaf J; Tack CJ; Stalenhoef AF
Curr Med Res Opin; 2005 Sep; 21(9):1469-76. PubMed ID: 16197666
[TBL] [Abstract][Full Text] [Related]
4. Effects of rosuvastatin versus atorvastatin on rho-associated coiled-coil containing protein kinase activity and endothelial function in patients with atherosclerosis.
Liu B; Cao HM; Li GY; Liu M; Feng J; Li J; Wang Q
J Int Med Res; 2011; 39(6):2314-22. PubMed ID: 22289549
[TBL] [Abstract][Full Text] [Related]
5. Effect of intensive lipid-lowering treatment compared to moderate lipid-lowering treatment with rosuvastatin on endothelial function in high risk patients.
Egede R; Jensen LO; Hansen HS; Antonsen L; Hansen KN; Junker A; Thayssen P
Int J Cardiol; 2012 Jul; 158(3):376-9. PubMed ID: 21349594
[TBL] [Abstract][Full Text] [Related]
6. The effects of treatment with atorvastatin versus rosuvastatin on endothelial dysfunction in patients with hyperlipidaemia.
Demir V; Doğru MT; Ede H; Yilmaz S; Alp C; Celik Y; Yildirim N
Cardiovasc J Afr; 2018 May/Jun 23; 29(3):162-166. PubMed ID: 29528361
[TBL] [Abstract][Full Text] [Related]
7. Effects of statins on vascular endothelial function in hypercholesterolemic patients with type 2 diabetes mellitus: fluvastatin vs. rosuvastatin.
Tomizawa A; Hattori Y; Suzuki K; Okayasu T; Kase H; Satoh H; Kasai K
Int J Cardiol; 2010 Sep; 144(1):108-9. PubMed ID: 19174316
[No Abstract] [Full Text] [Related]
8. Effect of atorvastatin versus rosuvastatin on levels of serum lipids, inflammatory markers and adiponectin in patients with hypercholesterolemia.
Qu HY; Xiao YW; Jiang GH; Wang ZY; Zhang Y; Zhang M
Pharm Res; 2009 Apr; 26(4):958-64. PubMed ID: 19082693
[TBL] [Abstract][Full Text] [Related]
9. A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases.
Soltész P; Dér H; Kerekes G; Szodoray P; Szücs G; Dankó K; Shoenfeld Y; Szegedi G; Szekanecz Z
Clin Rheumatol; 2009 Jun; 28(6):655-62. PubMed ID: 19224126
[TBL] [Abstract][Full Text] [Related]
10. Effect of rosuvastatin on ROCK activity, endothelial function, and inflammation in Asian patients with atherosclerosis.
Liu B; Zhang JY; Cao HM; Wang Q; Wang HB
Intern Med; 2012; 51(10):1177-82. PubMed ID: 22687786
[TBL] [Abstract][Full Text] [Related]
11. Effects of rosuvastatin on serum lipids and arteriosclerosis in dyslipidemic patients with cerebral infarction.
Deguchi I; Horiuchi Y; Hayashi T; Sehara Y; Kato Y; Ohe Y; Fukuoka T; Maruyama H; Sano H; Nagamine Y; Tanahashi N
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2007-2011. PubMed ID: 25066602
[TBL] [Abstract][Full Text] [Related]
12. Omega-3 fatty acids plus rosuvastatin improves endothelial function in South Asians with dyslipidemia.
Mindrescu C; Gupta RP; Hermance EV; DeVoe MC; Soma VR; Coppola JT; Staniloae CS
Vasc Health Risk Manag; 2008; 4(6):1439-47. PubMed ID: 19337557
[TBL] [Abstract][Full Text] [Related]
13. Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications.
Szucs G; Tímár O; Szekanecz Z; Dér H; Kerekes G; Szamosi S; Shoenfeld Y; Szegedi G; Soltész P
Rheumatology (Oxford); 2007 May; 46(5):759-62. PubMed ID: 17244666
[TBL] [Abstract][Full Text] [Related]
14. High-dose atorvastatin in peripheral arterial disease (PAD): effect on endothelial function, intima-media-thickness and local progression of PAD. An open randomized controlled pilot trial.
Spring S; Simon R; van der Loo B; Kovacevic T; Brockes C; Rousson V; Amann-Vesti B; Koppensteiner R
Thromb Haemost; 2008 Jan; 99(1):182-9. PubMed ID: 18217152
[TBL] [Abstract][Full Text] [Related]
15. Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis.
Végh E; Kerekes G; Pusztai A; Hamar A; Szamosi S; Váncsa A; Bodoki L; Pogácsás L; Balázs F; Hodosi K; Domján A; Szántó S; Nagy Z; Szekanecz Z; Szűcs G
Rheumatol Int; 2020 Mar; 40(3):427-436. PubMed ID: 31848735
[TBL] [Abstract][Full Text] [Related]
16. Short-term statin treatment does not prevent ischemia and reperfusion-induced endothelial dysfunction in humans.
Wouters CW; Wever KE; Bronckers I; Hopman MT; Smits P; Thijssen DH; Rongen GA
J Cardiovasc Pharmacol; 2012 Jan; 59(1):22-8. PubMed ID: 21885990
[TBL] [Abstract][Full Text] [Related]
17. Additive effect of homocysteine- and cholesterol-lowering therapy on endothelium-dependent vasodilation in patients with cardiovascular disease.
Wustmann K; Klaey M; Burow A; Shaw SG; Hess OM; Allemann Y
Cardiovasc Ther; 2012 Oct; 30(5):277-86. PubMed ID: 21884007
[TBL] [Abstract][Full Text] [Related]
18. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial.
Ridker PM; Danielson E; Fonseca FA; Genest J; Gotto AM; Kastelein JJ; Koenig W; Libby P; Lorenzatti AJ; Macfadyen JG; Nordestgaard BG; Shepherd J; Willerson JT; Glynn RJ;
Lancet; 2009 Apr; 373(9670):1175-82. PubMed ID: 19329177
[TBL] [Abstract][Full Text] [Related]
19. [Rosuvastatin and fenofibrate in patients with diabetes and low high density lipoprotein cholesterol: comparison of changes of lipid levels and some markers of inflammation].
Polenova NV; Vaulin NA; Masenko VP; Iavelov IS; Gratsianskiĭ NA
Kardiologiia; 2009; 49(2):9-14. PubMed ID: 19254210
[TBL] [Abstract][Full Text] [Related]
20. Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes.
Bellia A; Rizza S; Galli A; Fabiano R; Donadel G; Lombardo MF; Cardillo C; Sbraccia P; Tesauro M; Lauro D
Atherosclerosis; 2010 May; 210(1):199-201. PubMed ID: 20018286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
